Skip to content

In the BioHarmony Drug Report Database


Rescriptor (delavirdine) is a small molecule pharmaceutical. Delavirdine was first approved as Rescriptor on 1997-04-04. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA.
Trade Name Rescriptor
Common Name Delavirdine
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals
Get full access now